CVA Family Office’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.9K | Hold |
230
| – | – | ﹤0.01% | 736 |
|
|
2025
Q1 | $16K | Hold |
230
| – | – | ﹤0.01% | 721 |
|
|
2024
Q4 | $19.8K | Hold |
230
| – | – | ﹤0.01% | 679 |
|
|
2024
Q3 | $27.4K | Sell |
230
-1,652
| -88% | -$197K | ﹤0.01% | 605 |
|
|
2024
Q2 | $269K | Buy |
1,882
+100
| +6% | +$14.3K | 0.05% | 202 |
|
|
2024
Q1 | $229K | Hold |
1,782
| – | – | 0.04% | 219 |
|
|
2023
Q4 | $184K | Buy |
+1,782
| New | +$184K | 0.04% | 243 |
|
|
2023
Q3 | – | Sell |
-1,652
| Closed | -$134K | – | 707 |
|
|
2023
Q2 | $134K | Hold |
1,652
| – | – | 0.03% | 273 |
|
|
2023
Q1 | $131K | Hold |
1,652
| – | – | 0.03% | 272 |
|
|
2022
Q4 | $112K | Hold |
1,652
| – | – | 0.03% | 277 |
|
|
2022
Q3 | $82K | Hold |
1,652
| – | – | 0.02% | 272 |
|
|
2022
Q2 | $92K | Hold |
1,652
| – | – | 0.03% | 258 |
|
|
2022
Q1 | $92K | Sell |
1,652
-820
| -33% | -$45.7K | 0.02% | 276 |
|
|
2021
Q4 | $138K | Buy |
+2,472
| New | +$138K | 0.03% | 200 |
|
|
2021
Q3 | – | Sell |
-2,472
| Closed | -$104K | – | 707 |
|
|
2021
Q2 | $104K | Buy |
+2,472
| New | +$104K | 0.03% | 236 |
|